NATIXIS – Apellis Pharmaceuticals, Inc. Transaction History
NATIXIS portfolio value:
$19.26M
portfolio value
NATIXIS quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -10.19% | -32K shares | 5.06M | $68.3 | 282K |
| Q2 2022 | share | Increase | +17.12% | 45.9K shares | 577K | $45.22 | 314K |
| Q1 2022 | share | Increase | 0.00% | 268.1K shares | 13.62M | $50.81 | 268.1K |
| Q4 2021 | share | Decrease | -100.00% | -216.5K shares | -7.13M | $47.95 | 0 |
| Q3 2021 | share | Increase | +98.26% | 107.3K shares | 235K | $32.96 | 216.5K |
| Q2 2021 | share | Increase | 0.00% | 109.2K shares | 6.90M | $63.2 | 109.2K |